Director of Plus Therapeutics, Inc. (NASDAQ:PSTV), Clowes Howard, buys 3,000 shares worth $7,260

According to Plus Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Mar 04 06:15 AM, company Director, Clowes Howard disclosed buying 3,000 shares at a cost of $2.42. At the time of this transaction (Mar 03), this trade was worth $7,260 in total. As of Mar 03, Clowes Howard now owns 3,000 shares in total worth about $7,200.0.

For the last few recent trades made by Plus Therapeutics, Inc. (NASDAQ:PSTV) Director, Clowes Howard, we have the following information:

Posted by George Daniels on Thursday March 04 2021, 8:23 AM EST. All trademarks acknowledged. Filed under Business, Stocks. Comments and Trackbacks closed. Follow responses: RSS 2.0